Table 2.
Characteristic | No. of Patients (n = 225) | % |
---|---|---|
Age, years | ||
< 1 (infants) | 8 | 3.6 |
1-9 | 151 | 67.1 |
≥ 10 | 66 | 29.3 |
WBC counts/μL | ||
< 50,000 | 148 | 72.9 |
≥ 50,000 | 55 | 27.1 |
Unknown | 22 | |
NCI risk criteria at diagnosis | ||
Non-infants, standard risk | 102 | 45.3 |
Non-infants, high risk | 99 | 44.0 |
Non-infants, unknown | 16 | 7.1 |
Infants | 8 | 3.6 |
Sex | ||
Female | 93 | 41.3 |
Male | 132 | 58.7 |
Testis positive | ||
Yes | 4 | 1.9 |
No | 212 | 98.1 |
Unknown | 9 | |
Mediastinal mass | ||
Yes | 7 | 3.2 |
No | 209 | 96.8 |
Unknown | 9 | |
CNS disease | ||
Yes | 18 | 8.3 |
No | 198 | 91.7 |
Unknown | 9 | |
Immunophenotype | ||
Pre B cell | 195 | 86.7 |
T cell | 30 | 13.3 |
Karyotype | ||
Normal | 74 | 43.0 |
Hypodiploidy | 8 | 4.7 |
Hyperdiploidy | 16 | 9.3 |
t(12;21) | 3 | 1.7 |
t(1;19) | 8 | 4.7 |
t(4;11) | 2 | 1.2 |
t(9;22) | 4 | 2.3 |
Other | 57 | 33.1 |
Unknown | 53 |
Abbreviations: ALL, acute lymphoblastic leukemia; NCI, National Cancer Institute.